Bordetella pertussis, the causative agent of whooping cough, producess several biologically active products whose mechanisms of action and roles in bacterial virulence and pathogenicity remain unclear. One of these, Bordetella extractyoplasmic adenylate cyclase (ECAC), is receiving increasing attention as a novel bacterial product which is able to modify the function of selected eukaryotic cells. This bacterial enzyme is predominantly extracytoplasmic in location and is activated by the calcium-dependent regulatory protein, calmodulin, which is produced only by eukaryotic cells. In recent studies from this laboratory and others, it has been shown that extracts of B. pertussis and B. parapertussis are able to increase cAMP levels in human lymphocytes, monocytes and macrophages and inhibit several immunologic functions. Because of the crude preparations involved, however, it has not been possible to determine specifically if the ECAC is solely responsible for these effects and what the mechanisms are. Therefore, the goals of this renewal project are to purify the ECAC from B. pertussis and B. parapertussis, characterize its structure, and investigate its mechanism of action. Because previous purification of ECAC yielded a product with enzymatic, but no biological activity, it is essential that both paramenters be followed concurrently throughout purification. Biological activity will be monitored by ability to increase cAMP levels in target cells and to inhibit monocyte oxidative responses. ECAC binding and entry into susceptible target cells will be investigated. A novel approach to study ECAC is being provided by the mouse lymphoma cell line S49, which is killed by increased cAMP levels, ECAC receptor (binding) and entry mutants are being selected by exposure to the enzyme. These studies proposed herein are important to bacterial toxinology in that a similar ECAC has recently been identified from B. pertussis. Furthermore, the possibility that immunologic defects induced by Bordetella ECAC may contribute to the morbidity and mortality from whooping cough make the study of this mechanism and design for specific pharmacologic intervention essential. Finally, better understanding of the tissue specificity and mechanism of action may enable this novel bacterial product to be used as a probe in other areas of biomedical research.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI018000-05
Application #
3127624
Study Section
Bacteriology and Mycology Subcommittee 1 (BM)
Project Start
1980-09-01
Project End
1987-11-30
Budget Start
1985-12-01
Budget End
1986-11-30
Support Year
5
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Virginia
Department
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Gonyar, Laura A; Gray, Mary C; Christianson, Gregory J et al. (2017) Albumin, in the Presence of Calcium, Elicits a Massive Increase in Extracellular Bordetella Adenylate Cyclase Toxin. Infect Immun 85:
Wang, Xianzhe; Stapleton, James A; Klesmith, Justin R et al. (2017) Fine Epitope Mapping of Two Antibodies Neutralizing the Bordetella Adenylate Cyclase Toxin. Biochemistry 56:1324-1336
Hoffman, Casandra; Eby, Joshua; Gray, Mary et al. (2017) Bordetella adenylate cyclase toxin interacts with filamentous haemagglutinin to inhibit biofilm formation in vitro. Mol Microbiol 103:214-228
Wang, Xianzhe; Gray, Mary C; Hewlett, Erik L et al. (2015) The Bordetella adenylate cyclase repeat-in-toxin (RTX) domain is immunodominant and elicits neutralizing antibodies. J Biol Chem 290:3576-91
Hewlett, Erik L; Burns, Drusilla L; Cotter, Peggy A et al. (2014) Pertussis pathogenesis--what we know and what we don't know. J Infect Dis 209:982-5
Eby, Joshua C; Gray, Mary C; Hewlett, Erik L (2014) Cyclic AMP-mediated suppression of neutrophil extracellular trap formation and apoptosis by the Bordetella pertussis adenylate cyclase toxin. Infect Immun 82:5256-69
Masin, Jiri; Fiser, Radovan; Linhartova, Irena et al. (2013) Differences in purinergic amplification of osmotic cell lysis by the pore-forming RTX toxins Bordetella pertussis CyaA and Actinobacillus pleuropneumoniae ApxIA: the role of pore size. Infect Immun 81:4571-82
Eby, Joshua C; Gray, Mary C; Warfel, Jason M et al. (2013) Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection. Infect Immun 81:1390-8
Donato, Gina M; Goldsmith, Cynthia S; Paddock, Christopher D et al. (2012) Delivery of Bordetella pertussis adenylate cyclase toxin to target cells via outer membrane vesicles. FEBS Lett 586:459-65
Henderson, Michael W; Inatsuka, Carol S; Sheets, Amanda J et al. (2012) Contribution of Bordetella filamentous hemagglutinin and adenylate cyclase toxin to suppression and evasion of interleukin-17-mediated inflammation. Infect Immun 80:2061-75

Showing the most recent 10 out of 57 publications